Brown-Forman (BFB) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
18 Jun, 2026Executive summary
Annual Meeting scheduled for July 23, 2026, at Churchill Downs, Louisville, KY, with voting on directors, executive compensation, and auditor ratification.
Board emphasizes balancing heritage with innovation, focusing on long-term value and generational success.
Company returned $427 million in dividends and repurchased $400 million in stock during fiscal 2026.
Fiscal 2026 saw a 1% decrease in reported net sales and a 10% decrease in reported operating income, with flat organic sales and a 2% organic operating income decline.
Voting matters and shareholder proposals
Shareholders will vote on: election of eleven directors, advisory approval of executive compensation, and ratification of Ernst & Young LLP as independent auditor for fiscal 2027.
Board recommends voting FOR all proposals.
Shareholders may also vote on any other business properly brought before the meeting.
Board of directors and corporate governance
Board consists of eleven nominees, including six independent directors, four Brown family members, and one management director.
Chairman is a Brown family member; CEO and Chairman roles are separated.
Board committees: Audit, Compensation, Corporate Governance and Nominating, and Executive.
Board voluntarily maintains a majority of independent directors and fully independent Compensation and Audit Committees.
Annual self-assessment and director tenure limits are in place.
Latest events from Brown-Forman
- Net sales fell 1%, but gross margin and cash flow improved; 2027 outlook flat with cost headwinds.BFB
Q4 20265 Jun 2026 - Net sales fell 2% and EPS dropped 8% as emerging markets offset US and tequila declines.BFB
Q3 202628 Apr 2026 - Emerging markets and premium brand expansion drive growth amid U.S. demand softness.BFB
UBS Global Consumer and Retail Conference11 Mar 2026 - Operating income rose 25% and gross margin expanded, despite a 1% sales decline.BFB
Q4 20241 Feb 2026 - Sales and profit declined, but organic growth guidance and dividend increases were reaffirmed.BFB
Q1 202522 Jan 2026 - Cyclical market shifts, global expansion, and efficiency drive a decade-long growth ambition.BFB
Barclays 17th Annual Global Consumer Staples Conference22 Jan 2026 - Portfolio shifts, premiumization, and global RTD growth drive recovery amid U.S. market slowdown.BFB
TD Cowen's 2nd Annual Sip, Snack & Scrub Summit 202420 Jan 2026 - Net sales declined 5% in H1 FY25, but organic growth and guidance were reaffirmed.BFB
Q2 202511 Jan 2026 - U.S. distribution overhaul, cost savings, and emerging market growth drive future performance.BFB
Barclays 18th Annual Global Consumer Staples Conference 20255 Jan 2026